WinesWitter906

Strategy for one of the most lethal form of Breast cancers!

medicinal mushrooms - Inflammatory breast cancers, also referred to as IBC has been going to function as most lethal, yet sadly least understood out of all the types of breast cancer cells.

What exactly is known is that the lethality emanates from its inherent lack of tumor mass making it incredibly difficult to detect and it is way of attacking the lymphatic system.

Inflammatory Breast cancers is different from other stage 4 cervical cancer varieties in the way it forms what is called tumor spheroids. These specific kinds of tumors have been located being a lot more adhesive to cells.

There's been much research done lately on this type of cancer due to the extreme lethality.

Ganoderma mushroom - While surgery, drugs, radiation, chemotherapy along with other such intrusive treatments are already popular there exists a growing camp of forward thinking doctors who have seen amazing promise with the new shining star for oncologists.

Ganoderma (commercially sold as Karmic Balance ReishiCor) is a medicinal mushroom that's the leading ingredient in Karmic Balance ReishiCor.

Reishi contains biological compounds that are cytotoxic against cancer cells. Yes, you read that right- TOXIC towards the most dangerous type of Breast cancers cells!

Ganoderma mushroom - Multiple results reveal that Reishi selectively inhibits cancer cell viability although it does not affect the viability of noncancerous cells as shown in tests on mammals. Meaning it attacks the cell you want gone, and leaves the healthy ones alone!

Reishi gives Inflammatory Breast Cancer a 1-2 punch by attempting to break the tumor spheroids bond also. This one point alone gives Reishi incredible promise to use by those genetically predisposed to breast cancers.

Take the fight to breast cancer-be proactive!

http://www.karmicbalancehealth.com/reishicor-with-immune-assisttm.html

Nutr Cancer. 2011 Oct;63(7):1085-94. Epub 2011 Sep 2. Ganoderma lucidum (Reishi) inhibits cancer cell growth and expression of key molecules in inflammatory breast cancers. Martínez-Montemayor MM, Acevedo RR, Otero-Franqui E, Cubano LA, Dharmawardhane SF. Source Department of Biochemistry, Universidad Central del Caribe, Med school, Bayamón, Puerto Rico. mmmtz92@gmail.com